HIGHLIGHTS
- who: Enrica Cavedo from the AXA Research Fund and UPMC Chair, Paris, France have published the research work: Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer’s disease, in the Journal: Neurology, Hopital Pitié-Salpêtrière, Paris, France. 2Laboratory of Alzheimer's Neuroimaging and Epidemiology, of 31/07/2017
- what: Based on the data previously reported by the Hippocampus Study Clinical Trial (NCT00403520)13, 16 and the recent literature results suggesting an early involvement of BFCS in AD pathophysiology26, 28, 30, the objective of this explorative study is to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.